SCHEMBL30488015

SCHEMBL30488015

Nc1cc(-c2cccc(F)c2)nc(N)n1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.56
KMT2A Q03164 1/20 0.56
DYRK1A Q13627 3/20 0.51
ADORA2A P29274 6/20 0.50
ADORA1 P30542 5/20 0.50
ADORA2B P29275 1/20 0.48
MAP4K4 O95819 1/20 0.48
TAAR1 Q96RJ0 1/20 0.47
ACHE P22303 1/20 0.46
IDO1 P14902 1/20 0.45
CYP1A1 P04798 1/20 0.45
CYP1B1 Q16678 1/20 0.45
CCNT1 O60563 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CDK9 P50750 1/20 0.44
CHUK O15111 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29044811 1.00 KDM4E (0.56) KDM4EMEN1MAPTKMT2ADYRK1A
SCHEMBL5745564 0.83 ADORA2A (0.55) KDM4EMEN1MAPTKMT2AADORA2A
SCHEMBL5511069 0.79 KDM4E (0.64) KDM4EMAPTDYRK1AADORA2AADORA1
SCHEMBL28822368 0.79 NUDT1 (0.54) KDM4EMEN1MAPTKMT2AADORA2A
SCHEMBL11645510 0.79 ADORA2A (0.79) KDM4EMEN1MAPTKMT2ADYRK1A
SCHEMBL1358158 0.78 XDH (0.57) KDM4EMAPTDYRK1AADORA2AADORA1
SCHEMBL3923558 0.78 ASIC3 (0.62) KDM4EMEN1MAPTKMT2AADORA2A
SCHEMBL5229810 0.77 HSP90AA1 (0.62) KDM4EMEN1MAPTKMT2AADORA2A
SCHEMBL7711741 0.77 TAAR1 (0.59) KDM4EMEN1MAPTKMT2ADYRK1A
SCHEMBL30186623 0.76 KDM4E (0.53) KDM4EMEN1MAPTKMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113061116-B Aminopyrimidine compound, preparation method, composition and application thereof 上海医药工业研究院 2023-07-25 CN disclosed